CELCUITY INC. General and Administrative Expense
CELCUITY INC. (CELC) reported General and Administrative Expense of $27.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2026-03-26
- CELCUITY INC. general and administrative expense for the quarter ending 2025-12-31 was $11.57M, a 291.01% increase year-over-year.
- CELCUITY INC. general and administrative expense for the quarter ending 2025-09-30 was $7.93M, a 220.95% increase year-over-year.
- CELCUITY INC. general and administrative expense for the quarter ending 2025-06-30 was $3.79M, a 112.04% increase year-over-year.
- CELCUITY INC. general and administrative expense for the quarter ending 2025-03-31 was $3.91M, a 111.59% increase year-over-year.
- CELCUITY INC. general and administrative expense for fiscal 2025 was $27.20M, a 200.06% increase from fiscal 2024.
- CELCUITY INC. general and administrative expense for fiscal 2024 was $9.06M, a 60.81% increase from fiscal 2023.
- CELCUITY INC. general and administrative expense for fiscal 2023 was $5.64M, a 37.42% increase from fiscal 2022.
- CELCUITY INC. general and administrative expense for fiscal 2022 was $4.10M, a 57.88% increase from fiscal 2021.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 3 month as first filed | General and Administrative Expense 6 month | General and Administrative Expense 6 month as first filed | General and Administrative Expense 9 month | General and Administrative Expense 9 month as first filed | General and Administrative Expense 12 month | General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $11.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $19.50M derived: sum of 2 quarters · filed 2026-03-26 | $23.29M derived: sum of 3 quarters · filed 2026-03-26 | $27.20M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $7.93M 10-Q · filed 2025-11-13 | $11.72M derived: sum of 2 quarters · filed 2025-11-13 | $15.63M 10-Q · filed 2025-11-13 | $18.59M derived: sum of 4 quarters · filed 2026-03-26 | ||||
| 2025-06-30 | $3.79M 10-Q · filed 2025-08-14 | $7.69M 10-Q · filed 2025-08-14 | $10.65M derived: sum of 3 quarters · filed 2026-03-26 | $13.12M derived: sum of 4 quarters · filed 2026-03-26 | ||||
| 2025-03-31 | $3.91M 10-Q · filed 2025-05-15 | $6.87M derived: sum of 2 quarters · filed 2026-03-26 | $9.34M derived: sum of 3 quarters · filed 2026-03-26 | $11.12M derived: sum of 4 quarters · filed 2026-03-26 | ||||
| 2024-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $5.43M derived: sum of 2 quarters · filed 2026-03-26 | $7.22M derived: sum of 3 quarters · filed 2026-03-26 | $9.06M 10-K · filed 2026-03-26 | $9.06M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $2.47M 10-Q · filed 2025-11-13 | $2.47M 10-Q · filed 2024-11-14 | $4.26M derived: sum of 2 quarters · filed 2025-11-13 | $6.11M 10-Q · filed 2025-11-13 | $6.10M 10-Q · filed 2024-11-14 | $7.75M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $1.79M 10-Q · filed 2025-08-14 | $1.79M 10-Q · filed 2024-08-14 | $3.63M 10-Q · filed 2025-08-14 | $3.63M 10-Q · filed 2024-08-14 | $5.28M derived: sum of 3 quarters · filed 2025-08-14 | $6.69M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $1.85M 10-Q · filed 2025-05-15 | $1.85M 10-Q · filed 2024-05-15 | $3.49M derived: sum of 2 quarters · filed 2025-05-15 | $4.90M derived: sum of 3 quarters · filed 2025-05-15 | $6.21M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.06M derived: sum of 2 quarters · filed 2025-03-31 | $4.37M derived: sum of 3 quarters · filed 2025-03-31 | $5.64M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.41M 10-Q · filed 2024-11-14 | $2.72M derived: sum of 2 quarters · filed 2024-11-14 | $3.99M 10-Q · filed 2024-11-14 | $5.02M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.31M 10-Q · filed 2024-08-14 | $2.58M 10-Q · filed 2024-08-14 | $3.61M derived: sum of 3 quarters · filed 2024-08-14 | $4.64M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $1.27M 10-Q · filed 2024-05-15 | $2.30M derived: sum of 2 quarters · filed 2024-05-15 | $3.33M derived: sum of 3 quarters · filed 2024-05-15 | $4.56M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.06M derived: sum of 2 quarters · filed 2024-03-27 | $3.29M derived: sum of 3 quarters · filed 2024-03-27 | $4.10M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $1.02M 10-Q · filed 2023-11-13 | $2.26M derived: sum of 2 quarters · filed 2023-11-13 | $3.07M 10-Q · filed 2023-11-13 | $3.90M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.23M 10-Q · filed 2023-08-11 | $2.04M 10-Q · filed 2023-08-11 | $2.87M derived: sum of 3 quarters · filed 2023-08-11 | $3.51M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $811.29K 10-Q · filed 2023-05-15 | $1.64M derived: sum of 2 quarters · filed 2023-05-15 | $2.28M derived: sum of 3 quarters · filed 2023-05-15 | $2.85M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $829.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.47M derived: sum of 2 quarters · filed 2023-03-23 | $2.04M derived: sum of 3 quarters · filed 2023-03-23 | $2.60M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $639.27K 10-Q · filed 2022-11-10 | $1.21M derived: sum of 2 quarters · filed 2022-11-10 | $1.77M 10-Q · filed 2022-11-10 | $2.21M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $573.36K 10-Q · filed 2022-08-12 | $1.13M 10-Q · filed 2022-08-12 | $1.57M derived: sum of 3 quarters · filed 2022-08-12 | $2.09M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $555.43K 10-Q · filed 2022-05-16 | $999.49K derived: sum of 2 quarters · filed 2022-05-16 | $1.52M derived: sum of 3 quarters · filed 2022-05-16 | $1.96M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $444.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $961.53K derived: sum of 2 quarters · filed 2022-03-23 | $1.41M derived: sum of 3 quarters · filed 2022-03-23 | $1.87M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $517.47K 10-Q · filed 2021-11-09 | $965.18K derived: sum of 2 quarters · filed 2021-11-09 | $1.43M 10-Q · filed 2021-11-09 | $1.83M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $447.71K 10-Q · filed 2021-08-11 | $911.11K 10-Q · filed 2021-08-11 | $1.31M derived: sum of 3 quarters · filed 2021-08-11 | $1.69M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $463.40K 10-Q · filed 2021-05-10 | $864.14K derived: sum of 2 quarters · filed 2021-05-10 | $1.24M derived: sum of 3 quarters · filed 2021-05-10 | $1.62M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $400.74K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $780.46K derived: sum of 2 quarters · filed 2021-02-16 | $1.15M derived: sum of 3 quarters · filed 2021-02-16 | $1.54M 10-K · filed 2021-02-16 | ||||
| 2019-09-30 | $379.72K 10-Q · filed 2020-11-09 | $751.71K derived: sum of 2 quarters · filed 2020-11-09 | $1.14M 10-Q · filed 2020-11-09 | $1.45M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $371.99K 10-Q/A · filed 2020-08-11 | $755.53K 10-Q/A · filed 2020-08-11 | $1.07M derived: sum of 3 quarters · filed 2020-08-11 | $1.45M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $383.55K 10-Q · filed 2020-05-07 | $700.01K derived: sum of 2 quarters · filed 2020-05-07 | $1.08M derived: sum of 3 quarters · filed 2020-05-07 | $1.46M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $316.46K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $693.26K derived: sum of 2 quarters · filed 2020-03-13 | $1.08M derived: sum of 3 quarters · filed 2020-03-13 | $1.61M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $376.80K 10-Q · filed 2019-11-07 | $759.44K derived: sum of 2 quarters · filed 2019-11-07 | $1.29M 10-Q · filed 2019-11-07 | $1.71M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $382.65K 10-Q · filed 2019-08-08 | $913.29K 10-Q · filed 2019-08-08 | $1.33M derived: sum of 3 quarters · filed 2019-08-08 | $1.50M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $530.64K 10-Q · filed 2019-05-07 | $951.60K derived: sum of 2 quarters · filed 2019-05-07 | $1.12M derived: sum of 3 quarters · filed 2019-05-07 | $1.42M derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | $420.96K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $585.63K derived: sum of 2 quarters · filed 2019-03-01 | $887.45K derived: sum of 3 quarters · filed 2019-03-01 | $972.52K 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $164.66K 10-Q · filed 2018-11-13 | $466.49K derived: sum of 2 quarters · filed 2018-11-13 | $551.55K 10-Q · filed 2018-11-13 | $619.14K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $301.82K 10-Q · filed 2018-08-09 | $386.96K 10-Q · filed 2018-08-09 | $454.47K derived: sum of 3 quarters · filed 2018-08-09 | $519.21K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $85.14K 10-Q · filed 2018-05-14 | $152.65K derived: sum of 2 quarters · filed 2018-05-14 | $217.39K derived: sum of 3 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | $67.51K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $132.25K derived: sum of 2 quarters · filed 2018-03-15 | $263.66K 10-K · filed 2018-03-15 | |||||
| 2016-09-30 | $64.74K 10-Q · filed 2017-12-01 | $196.16K 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |